Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Blood drug"'
Publikováno v:
The Breast Journal. 26:743-747
Mastalgia affects premenopausal in which cyclical mastalgia affects up to 40% of women. In approximately 8% of these women, pain will be severe and interfere with their normal activities. oral tamoxifen widely used in the treatment of mastalgia is as
Publikováno v:
Chinese Medical Journal
Chinese Medical Journal, Vol 129, Iss 2, Pp 194-199 (2016)
Chinese Medical Journal, Vol 129, Iss 2, Pp 194-199 (2016)
Background: Recently, local sustained-release antibiotics systems have been developed because they can increase local foci of concentrated antibiotics without increasing the plasma concentration, and thereby effectively decrease any systemic toxicity
Autor:
Michele Iuliani, Alfredo Berruti, Giuseppe Tonini, Francesca Vignani, Bruno Vincenzi, Consuelo Buttigliero, Alice Zoccoli, Daniele Santini, Giulia Ribelli, Giorgio V. Scagliotti, Valentina Bertaglia, Marcello Tucci, Francesco Pantano, Marco Fioramonti
Publikováno v:
Onkourologiâ, Vol 11, Iss 4, Pp 81-88 (2015)
Oncotarget, 6 (14
Oncotarget
Oncotarget, 6 (14
Oncotarget
Abiraterone acetate (ABI) is associated not only with a significant survival advantage in both chemotherapy-naive and -treated patients with metastatic castration-resistant prostate cancer (mCRPC), but also with a delay in time to development of Skel
Autor:
Jong Cheol Jeong, Duck Jong Han, Hyosang Kim, Curie Ahn, Won Seok Yang, Jung Sik Park, Su Kil Park, Jaeseok Yang
Publikováno v:
Clinical Transplantation. 29:142-148
We investigated the effects of pregnancy and delivery on renal function in transplant recipients and the relationship between doses of immunosuppressants and blood drug levels during pregnancy in 75 women with 88 deliveries. Significant serum creatin
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia
Autor:
Giancarlo Agnelli, Maurizio Paciaroni, Paolo Eusebi, Katiuscia Nardi, Paolo Milia, Valeria Caso
Publikováno v:
Journal of Diabetes and its Complications. 26:70-76
Admission hyperglycemia increases the risk of death in patients with acute stroke. However, the most appropriate cut-off of glucose level indicating an increased risk of short-term mortality remains unknown.We aimed at establishing the optimum cut-of
Autor:
Nai-Kuan Chou, Yih-Sharng Chen, Hsi-Yu Yu, C.-I. Tsao, Nai-Hsin Chi, Shoei-Shen Wang, Szu-Fen Huang, C.-Y. Tsan, Chih-Hsien Wang, Chia-Tung Shun, I-Hui Wu
Publikováno v:
Transplantation proceedings. 48(3)
Background Transplantation and immunosuppressive drugs are major limitations to the success of pregnancy. In 1988, the first pregnancy after a heart transplant was reported, which has given female recipients the hope to give birth. During pregnancy,
Autor:
Dimitrios Pahatouridis, Dimitrios Drosos, George A. Alexiou, Spyridon Voulgaris, Evaggelos Mihos, Andreas Zigouris
Publikováno v:
Brain Injury. 24:1189-1192
INTRODUCTION: Abnormalities in blood coagulation are relatively common after traumatic brain injury (TBI). We prospectively studied the safety of the early antithrombotic prophylaxis with low molecular weight heparin. METHODS: We prospectively evalua
Autor:
Georg Martin Fiedler, Alexander Benedikt Leichtle, Uta Ceglarek, Joachim Thiery, Gabor Gäbel, Helmut Witzigmann
Publikováno v:
Journal of Transplantation. 2010:1-6
Background. Close therapeutic drug monitoring of Cyclosporine (CsA) in transplant outpatients is a favourable procedure to maintain the long-term blood drug levels within their respective narrow therapeutic ranges. Compared to basal levels (C0), CsA
Autor:
Maria O. Vannozzi, Maurizio Nicodemo, Gianluca Damonte, Andrea Armirotti, Marco Venturini, Lucia Cavallini, Gianluigi Lunardi
Publikováno v:
Clinical Therapeutics. 31:1812-1819
Background: Intravenous temsirolimus, an inhibitor of the mammalian target of rapamycin (mTOR), is approved for the treatment of advanced renal cell carcinoma (RCC). Sirolimus, the principal metabolite of temsirolimus in humans, also exhibits mTOR in
Autor:
Michael Schiff, Xianhuang Zhou, S. Kelly, J E Huffstutter, V Rodriguez-Valverde, K Bahrt, Tracy Li, C Pritchard, Patrick Durez, Mark C. Genovese, M. Le Bars
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 68, no. 11, p. 1708-1714 (2009)
Annals of the Rheumatic Diseases, Vol. 68, no. 11, p. 1708-1714 (2009)
Objective: To assess the safety, tolerability and efficacy of abatacept in patients with rheumatoid arthritis (RA) who had failed anti-tumour necrosis factor (TNF) therapy and were switched to abatacept directly or after completing washout. Methods: